[Systemic lupus erythematosus].
Kneitz
C
C
Medizinische Poliklinik, Schwerpunkt Rheumatologie und Klinische Immunologie, Universitate Wurzburg
Goebeler
M
M
Tony
H P
HP
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000974:Antibodies, Antinuclear / Q000097:blood; D004247:DNA / Q000276:immunology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008134:Long-Term Care; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D020945:Lupus Vasculitis, Central Nervous System / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D011379:Prognosis
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D007166:Immunosuppressive Agents; D004247:DNA